Hyperparathyroidism-jaw tumor syndrome

被引:21
|
作者
Kutcher, Matthew R. [1 ]
Rigby, Matthew H. [2 ]
Bullock, Martin [3 ]
Trites, Jonathan [4 ]
Taylor, S. Mark [4 ]
Hart, Robert D. [2 ]
机构
[1] Dalhousie Univ, Fac Med, Halifax, NS, Canada
[2] Dalhousie Univ, Div Otolaryngol Head & Neck Surg, Halifax, NS, Canada
[3] Dalhousie Univ, Dept Anat Pathol, Halifax, NS, Canada
[4] Dalhousie Univ, Dept Surg, Div Otolaryngol, Halifax, NS B3H 4H2, Canada
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2013年 / 35卷 / 06期
关键词
hyperparathyroidjaw tumor syndrome; hyperparathyroidism; parathyroid carcinoma; parathyroidectomy; hypercalcemia; HRPT2;
D O I
10.1002/hed.22918
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background Hyperparathyroidismjaw tumor (HPT-JT) syndrome is a rare autosomal dominant multiple tumor syndrome characterized by hyperparathyroidism due to single or multiple-gland parathyroid tumor(s). Since it was first described in 1990, the genetics underlying the syndrome have been elucidated and typical clinical presentations are becoming clarified as literature describing this rare entity amasses. Methods and Results A 22-year-old man presented with a 2-year history of fatigue, weight loss, nausea, and vomiting. Anemia workup indicated severe hypercalcemia. Investigations were consistent with a diagnosis of HPT-JT. The patient underwent a total 4-gland parathyroidectomy with single gland reimplantation. Conclusion HPT-JT is a complex syndrome with phenotypic manifestations that can seem physiologically and temporally unrelated. The risk of parathyroid carcinoma is elevated in patients with HPT-JT, necessitating rapid treatment and complete tumor resection to reduce the morbidity and mortality associated with intractable hypercalcemia due to local recurrence or metastatic disease. (c) 2012 Wiley Periodicals, Inc. Head Neck 35: E175-E177, 2013
引用
收藏
页码:E175 / E177
页数:3
相关论文
共 50 条
  • [21] Hyperparathyroidism - jaw tumor syndrome: a report of three large kindred
    Iacobone, Maurizio
    Masi, Giulia
    Barzon, Luisa
    Porzionato, Andrea
    Macchi, Veronica
    Ciarleglio, Francesco Antonio
    Palu, Giorgio
    De Caro, Raffaele
    Viel, Giovanni
    Favia, Gennaro
    LANGENBECKS ARCHIVES OF SURGERY, 2009, 394 (05) : 817 - 825
  • [22] Insights into Hyperparathyroidism-Jaw Tumour Syndrome: From Endocrine Acumen to the Spectrum of CDC73 Gene and Parafibromin-Deficient Tumours
    Gheorghe, Ana-Maria
    Sima, Oana-Claudia
    Florescu, Alexandru Florin
    Ciuche, Adrian
    Nistor, Claudiu
    Sandru, Florica
    Carsote, Mara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (04)
  • [23] Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression
    Geoffrey E Woodard
    Ling Lin
    Jian-Hua Zhang
    Sunita K Agarwal
    Stephen J Marx
    William F Simonds
    Oncogene, 2005, 24 : 1272 - 1276
  • [24] Cell Division Cycle Protein 73 Homolog (CDC73) Mutations in the Hyperparathyroidism-Jaw Tumor Syndrome (HPT-JT) and Parathyroid Tumors
    Newey, Paul J.
    Bowl, Michael R.
    Cranston, Treena
    Thakker, Rajesh V.
    HUMAN MUTATION, 2010, 31 (03) : 295 - 307
  • [25] HIGH RISK OF PARATHYROID CARCINOMA AND GENETIC SCREENING IN THE FIRST DIAGNOSED ROMANIAN FAMILY WITH HYPERPARATHYROIDISM-JAW TUMOR SYNDROME AND A GERMLINE MUTATION OF THE CDC73 GENE
    Grigorie, D.
    Sucaliuc, A.
    Ciuffi, S.
    Franceschelli, F.
    Marini, F.
    Ioachim, D.
    Terzea, D.
    Brandi, M. L. L.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2019, 15 (03) : 398 - 403
  • [26] Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese
    Kong, Jing
    Wang, Ou
    Nie, Min
    Shi, Jie
    Hu, Yingying
    Jiang, Yan
    Li, Mei
    Xia, Weibo
    Meng, Xunwu
    Xing, Xiaoping
    CLINICAL ENDOCRINOLOGY, 2014, 81 (02) : 222 - 230
  • [27] Jaw tumor in recurrent primary hyperparathyroidism: A case report
    Nezhad, Farzaneh Amini
    Payab, Moloud
    Nayebandi, Sara
    Hasani-Ranjbar, Shirin
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2018, 52 : 54 - 58
  • [28] Large intragenic deletion of CDC73 (exons 4-10) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family
    Guarnieri, Vito
    Seaberg, Raewyn M.
    Kelly, Catherine
    Davidson, M. Jean
    Raphael, Simon
    Shuen, Andrew Y.
    Baorda, Filomena
    Palumbo, Orazio
    Scillitani, Alfredo
    Hendy, Geoffrey N.
    Cole, David E. C.
    BMC MEDICAL GENETICS, 2017, 18
  • [29] Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias
    Gill, Anthony J.
    Clarkson, Adele
    Gimm, Oliver
    Keil, Juliane
    Dralle, Henning
    Howell, Viive M.
    Marsh, Deborah J.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (09) : 1140 - 1149
  • [30] Hyperparathyroidism Jaw-Tumor Syndrome: A Case Report From a Radiological View
    Khan, Muhammad Mehraiz
    Fazli, Huda
    Khan, Touseef Bilal
    Tehrany, Pooya M.
    Bacani, Niempa
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)